lastar a has been researched along with Liver Dysfunction in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Aziz, MA; Abdel-Hamid, NM; Bakar, S; Mohafez, OM; Mohamed, EM; Wahid, A | 1 |
1 other study(ies) available for lastar a and Liver Dysfunction
| Article | Year |
|---|---|
New pathways driving the experimental hepatoprotective action of tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl) against acute hepatotoxicity.
Topics: Acute Disease; Animals; Carbon Tetrachloride; Caspase 3; Catalase; Cyclic N-Oxides; Gene Expression Regulation; Glutathione; Liver; Liver Diseases; Male; Membrane Proteins; Mice; Piperidines; Protective Agents; Protein Serine-Threonine Kinases; RNA, Messenger; Signal Transduction; Spin Labels; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha | 2016 |